As of 2026-04-04, the Relative Valuation of Huapont Life Sciences Co Ltd (002004.SZ) is (1.01) CNY. This relative valuation is based on P/E multiples. With the latest stock price at 5.17 CNY, the upside of Huapont Life Sciences Co Ltd based on Relative Valuation is -119.6%.
The range of the Relative Valuation is (0.86) - (0.92) CNY.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.1x - 21.4x | 16.1x |
| Forward P/E multiples | 12.2x - 13.1x | 12.8x |
| Fair Price | (0.86) - (0.92) | (1.01) |
| Upside | -116.6% - -117.8% | -119.6% |
| Date | P/E |
| 2026-03-13 | -80.11 |
| 2026-03-12 | -79.82 |
| 2026-03-11 | -77.69 |
| 2026-03-10 | -77.41 |
| 2026-03-09 | -77.55 |
| 2026-03-06 | -79.11 |
| 2026-03-05 | -76.13 |
| 2026-03-04 | -75.84 |
| 2026-03-03 | -77.12 |
| 2026-03-02 | -79.97 |
| 2026-02-27 | -79.11 |
| 2026-02-26 | -78.83 |
| 2026-02-25 | -78.69 |
| 2026-02-24 | -78.12 |
| 2026-02-13 | -76.27 |
| 2026-02-12 | -77.69 |
| 2026-02-11 | -77.83 |
| 2026-02-10 | -77.41 |
| 2026-02-09 | -78.12 |
| 2026-02-06 | -78.26 |
| 2026-02-05 | -77.41 |
| 2026-02-04 | -78.54 |
| 2026-02-03 | -77.97 |
| 2026-02-02 | -76.69 |
| 2026-01-30 | -79.68 |
| 2026-01-29 | -79.97 |
| 2026-01-28 | -82.67 |
| 2026-01-27 | -82.53 |
| 2026-01-26 | -83.67 |
| 2026-01-23 | -80.39 |
| 2026-01-22 | -78.26 |
| 2026-01-21 | -76.84 |
| 2026-01-20 | -80.39 |
| 2026-01-19 | -79.11 |
| 2026-01-16 | -77.41 |
| 2026-01-15 | -76.41 |
| 2026-01-14 | -77.55 |
| 2026-01-13 | -70.43 |
| 2026-01-12 | -69.72 |
| 2026-01-09 | -69.58 |
| 2026-01-08 | -69.30 |
| 2026-01-07 | -69.15 |
| 2026-01-06 | -69.58 |
| 2026-01-05 | -68.44 |
| 2025-12-31 | -68.01 |
| 2025-12-30 | -68.44 |
| 2025-12-29 | -68.58 |
| 2025-12-26 | -69.44 |
| 2025-12-25 | -69.30 |
| 2025-12-24 | -69.30 |